First Manhattan’s Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share CTV.WS Stock Holding History

First Manhattan’s Portfolio CTV.WS Stock Details CTV.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,250	Closed	-$56	–	1380
2024 Q1	$56	Hold	1,250	–	–	﹤0.01%	1396
2023 Q4	$37	Hold	1,250	–	–	﹤0.01%	1425
2023 Q3	$87	Hold	1,250	–	–	﹤0.01%	1465
2023 Q2	$125	Hold	1,250	–	–	﹤0.01%	1399
2023 Q1	$125	Hold	1,250	–	–	﹤0.01%	1490
2022 Q4	$500	Hold	1,250	–	–	﹤0.01%	1608
2022 Q3	$0	Hold	1,250	–	–	﹤0.01%	1676
2022 Q2	$0	Hold	1,250	–	–	﹤0.01%	1689
2022 Q1	$1K	Hold	1,250	–	–	﹤0.01%	1568
2021 Q4	$1K	Buy	+1,250	New	+$1.55K	﹤0.01%	1551

Other funds holding CTV.WS

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Ulysses Management New York $802M AUM 5.35% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

First Manhattan's CTV.WS Position: Q2 2024 in Review

First Manhattan sold out of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) in Q2 2024, closing a stake of 1,250 shares — an estimated $56 sold.

First Manhattan first reported a position in CTV.WS in Q4 2021 and held it in 10 quarters. The position peaked at $1K in Q1 2022. 16 funds tracked by Wall St. Rank hold CTV.WS as of Q2 2024.

First Manhattan reported no remaining Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q2 2024 after selling out during the quarter.
First Manhattan sold 1,250 Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q2 2024, an estimated $56.
First Manhattan first reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q4 2021 and held it in 10 quarters.
First Manhattan's Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $1K in Q1 2022.
16 funds tracked by Wall St. Rank held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q2 2024.

Based on First Manhattan's 13F filing for Q2 2024, filed 14 Aug 2024.